Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to lift the "stigma" around using such medication
The active ingredient, Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a sophisticated and effective approach for individuals grappling with the challenges of diabetes management
Some studies have suggested that GLP-1 agonists could be associated with an increased risk of pancreatic issues, which could pose additional complications when considering pregnancy
If glycemic control is not achieved, 2 mg weekly is the maximum recommended dose
Since the first such case was filed in 2023, at least 4,400 patients have filed lawsuits that are now part of consolidated federal and state litigation, numbers that are expected to grow as part of legal challenges expected to take several years
The barrage of letters continues a crackdown on companies selling compounded versions of in-patent drugs that started last year, and has already resulted in warnings for prominent telehealth companies offering GLP-1s for weight loss, including Hims & Hers
.jpg)